Publications by authors named "Doug Wisniewski"

Claim this Profile
D
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®.
Timothy A Blizzard, Helen Chen, Seongkon Kim, Jane Wu, Rena Bodner, Doug Wisniewski

Bioorg Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Side chain SAR of bicyclic β-lactamase inhibitors (BLIs). 2. N-Alkylated and open chain analogs of MK-8712.
Helen Chen, Timothy A Blizzard, Seongkon Kim, Jane Wu, Katherine Young, Doug Wisniewski

Bioorg Med Chem Lett· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional analysis of sites within PCSK9 responsible for hypercholesterolemia.
Shilpa Pandit, Doug Wisniewski, Joseph C Santoro, Sookhee Ha, Vijayalakshmi Ramakrishnan

J Lipid Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation.
Timothy S Fisher, Paola Lo Surdo, Shilpa Pandit, Marco Mattu, Joseph C Santoro, Doug Wisniewski

J Biol Chem· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis